PMID: 6540170Aug 1, 1984Paper

Diurnal fluctuations in free and total steady-state plasma levels of carbamazepine and correlation with intermittent side effects

Epilepsia
R RivaA Baruzzi

Abstract

The relationship between diurnal fluctuations in free (unbound) and total plasma carbamazepine levels and the appearance of intermittent side effects was investigated in nine epileptic patients receiving chronic therapy with carbamazepine, alone or in combination with phenobarbital. On a three-times-daily or four-times-daily dosing schedule, both total and free carbamazepine levels fluctuated considerably (on an average, 41 and 45%, respectively, around the mean). Side effects (particularly diplopia and nystagmus) were observed in five patients and showed an intermittent pattern in four. Side effects were never found at total carbamazepine levels less than 34 mumol/L but invariably appeared at levels greater than 38 mumol/L. At levels between 34 and 38 mumol/L adverse effects were inconsistently observed. The correlation between plasma carbamazepine levels and manifestations of toxicity was slightly stronger when free rather than total levels were considered. Side effects were always apparent at free levels greater than 7.2 mumol/L. These data underline the limitations of relying on a single drug level determination during the monitoring of carbamazepine therapy and emphasize the necessity of carefully adjusting the dosing sche...Continue Reading

References

Mar 1, 1978·Clinical Pharmacokinetics·L Bertilsson
Sep 1, 1979·Clinical Pharmacology and Therapeutics·M EichelbaumG E von Unruh
Aug 1, 1978·Journal of Neurology, Neurosurgery, and Psychiatry·E PeruccaA Richens
Apr 1, 1975·Clinical Pharmacology and Therapeutics·W D HooperJ H Tyrer
Feb 1, 1982·Neurology·D E Jacome, R FitzGerald
Jun 1, 1982·Epilepsia·I H PatelL M Ojemann
Aug 1, 1982·Annals of Neurology·S D WheelerJ Weiss
Feb 1, 1964·Clinica Chimica Acta; International Journal of Clinical Chemistry·W G DUNCOMBE
Aug 1, 1976·British Journal of Clinical Pharmacology·S I JohannessenP L Morselli

❮ Previous
Next ❯

Citations

Jan 1, 1986·European Journal of Clinical Pharmacology·G J MacpheeM J Brodie
Jan 1, 1993·Life Sciences·B Bruguerolle, B Lemmer
Jan 1, 1988·Epilepsy Research·J SiveniusP Riekkinen
Sep 9, 1989·Lancet
Aug 1, 1997·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·A DelckerH C Diener
Oct 1, 1990·Journal of Clinical Pharmacy and Therapeutics·N IchikouT Aoyama
Jan 1, 1987·Epilepsia·W E Dodson
Jan 1, 1987·Epilepsia·W E Dodson
Jan 1, 1988·Epilepsia·W E Dodson
Mar 1, 1994·Epilepsia·W E HaefeliT F Lüscher
Mar 24, 1998·Annual Review of Medicine·C W Bazil, T A Pedley
Nov 15, 2013·Epilepsy Research·Alberto VerrottiGaetano Zaccara
May 1, 1997·Clinical Therapeutics·M K Bazil, C W Bazil
Mar 1, 2006·Neuropsychiatric Disease and Treatment·Richard H Weisler
Mar 5, 1998·Therapeutic Drug Monitoring·M BialerE Perucca
Jan 1, 1995·Pharmacology & Therapeutics·M C Walker, P N Patsalos
Jun 7, 2013·Expert Review of Neurotherapeutics·Gaetano ZaccaraAlfonso Iudice
Mar 16, 2001·Expert Opinion on Pharmacotherapy·J W Wheless, V Venkataraman
Sep 1, 1987·Medical Toxicology and Adverse Drug Experience·M J Eadie
May 20, 2009·L'Encéphale·B Bruguerolle
Jul 24, 2007·Annals of Emergency Medicine·Thomas B PurcellRobert Chavez
Nov 6, 2012·Acta Psychiatrica Scandinavica·Dan Cohen, Anton J M Loonen
Dec 8, 2004·Epilepsy & Behavior : E&B·Michael Privitera, David M Ficker
Mar 1, 1989·British Journal of Clinical Pharmacology·J G LarkinM J Brodie
Nov 1, 1989·Statistics in Medicine·A Racine-Poon, J P Dubois
Feb 1, 1991·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Z DhallaJ Sutton
Jan 1, 1986·European Journal of Clinical Pharmacology·G J MacPheeM J Brodie
Aug 1, 1990·Acta Neurologica Scandinavica·P K JensenM Dam
Mar 23, 1999·Biopharmaceutics & Drug Disposition·M OllingJ Meulenbelt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.